Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market (2025-2031) | Outlook, Segmentation, Competitive Landscape, Forecast, Companies, Analysis, Trends, Growth, Size & Revenue, Value, Industry, Share

Market Forecast By Biomarker Type (Serum Biomarkers, Biomarker Panels, Fibrosis Biomarkers, Imaging Biomarkers, Others), By End User (Hospitals, Diagnostic Centers, Others) And Competitive Landscape
Product Code: ETC8890118 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Portugal Non Alcoholic Steatohepatitis Nash Biomarkers Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Portugal`s import shipments of non-alcoholic steatohepatitis (NASH) biomarkers in 2024 continued to see high concentration from top exporting countries such as Netherlands, Spain, USA, Sweden, and UK. The Herfindahl-Hirschman Index (HHI) indicated a significant increase in market concentration from 2023 to 2024. Despite a negative growth rate in 2024 compared to the previous year, the compound annual growth rate (CAGR) from 2020 to 2024 remained strong at 56.26%. This suggests a competitive market landscape with potential opportunities for further expansion and diversification of import sources in the coming years.

Key Highlights of the Report:

  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Outlook
  • Market Size of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2024
  • Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenues & Volume for the Period 2021- 2031
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trend Evolution
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers and Challenges
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Porter's Five Forces
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Life Cycle
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Type for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Serum Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Panels for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Fibrosis Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Imaging Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Diagnostic Centers for the Period 2021- 2031
  • Historical Data and Forecast of Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Import Export Trade Statistics
  • Market Opportunity Assessment By Biomarker Type
  • Market Opportunity Assessment By End User
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Top Companies Market Share
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Competitive Benchmarking By Technical and Operational Parameters
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Company Profiles
  • Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

3.1 Portugal Country Macro Economic Indicators

3.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle

3.4 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces

3.5 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F

3.6 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Portugal

4.2.2 Growing awareness about the importance of early diagnosis and treatment of NASH

4.2.3 Technological advancements in biomarker testing for NASH

4.3 Market Restraints

4.3.1 Limited availability of specialized healthcare facilities for NASH diagnosis and treatment in Portugal

4.3.2 Stringent regulatory requirements for biomarker approval in the market

5 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends

6 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types

6.1 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type

6.1.1 Overview and Analysis

6.1.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F

6.1.3 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F

6.1.4 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F

6.1.5 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F

6.1.6 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F

6.1.7 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User

6.2.1 Overview and Analysis

6.2.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

6.2.4 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

7 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics

7.1 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries

7.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries

8 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators

8.1 Number of research studies or clinical trials focusing on NASH biomarkers in Portugal

8.2 Adoption rate of NASH biomarker testing in healthcare facilities

8.3 Number of partnerships or collaborations between biomarker companies and healthcare providers in Portugal

9 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment

9.1 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F

9.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F

10 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape

10.1 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024

10.2 Portugal Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All